Australian hospitals have adopted a new combination chemotherapy for bladder cancer that has brought remission rates to 60 ...

More than three decades ago, the U.S. Food and Drug Administration (FDA) approved Bacillus Calmette-Guérin (BCG) as the first ...

ASCO annual meeting featured a urothelial carcinoma oral abstract session and a discussant presentation by Dr. John Sfakianos ...

An international trial found combining a chemotherapy drug with an immunotherapy bladder cancer treatment is simple, safe and ...

Bladder cancer, a common malignancy, often presents subtle symptoms like blood in urine or painful urination.

We know from the phase 2 TROPHY-U-01 trial that sacituzumab govitecan is an active drug, with an objective response rate of ...

Bladder cancer is a cancer that forms in tissues of the bladder. Most bladder cancers are transitional cell carcinomas (cancer that begins in cells that normally make up the inner lining of the ...

Surgeons from Keck Medicine of USC and UCLA Health have performed the world's first-in-human bladder transplant.

Sonpavde serves as the medical director of genitourinary oncology, and is an assistant director of the Clinical Research Unit and the Christopher K. Glanz Chair for Bladder Cancer Research at the ...

More than three decades ago, the U.S. Food and Drug Administration (FDA) approved Bacillus Calmette-Guérin (BCG) as the first immunotherapy against cancer. And it is still used today to treat ...

The subtypes investigated in bladder cancer were CK19, CK20 and CK7 IHC/RT-PCR CK20: 56–46% [98,99]; CK7: 100% [99]; CK1: 93.1% [101] Association of CK19 with UPII detected pN0 patients with ...

The type of bladder cancer means the type of cell the cancer started in. Knowing this helps your doctor decide which treatment you need. The most common type of bladder cancer is urothelial bladder ...